All pages
Powered by GitBook
1 of 10

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Lump and mass

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Distinguishing consistently between lump and mass can be difficult in diagnostic contexts, as the terms are often used interchangeably or lack precise definitions. As a result, lump and mass have, in certain conditions, been treated as synonymous.

Avoid using 'lump' in new content, where more specific terminology is available.

Lump should not be added as a synonym for mass concepts in the Finding or Disorder hierarchies. Existing legacy synonyms and concepts will remain unchanged.

Provide Feedback

Abscess

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

There are two types of abscesses:

  1. septic

  2. sterile

Most abscesses are septic, which means that they are the result of an infection.

If a concept's meaning, based on its FSN and text definition, does not specify whether the abscess is sterile or septic, then the concept should not be modeled as septic.

Modeling Abscess in Procedures

The concept's logical definition uses the Indirect morphology (attribute) of 44132006 |Abscess (morphologic abnormality)| and a Direct substance (attribute) of 11311000 |Pus (substance)|.

Congenital anomaly

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Disorders which involve congenital anomalies are defined with:

  • Occurrence (attribute) = Congenital (qualifier value)

  • Associated morphology (attribute) = Morphologically abnormal structure (morphologic abnormality)

  • Pathological process (attribute) = Pathological development process (qualifier value)

Therefore, congenital does not need to be represented as the Associated morphology (attribute) target value. Congenital anomaly morphology concepts usually have non-congenital parents.

Morphologic Abnormality Modeling

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

The morphologic abnormality subhierarchy is located two levels below the Body structure hierarchy with siblings Apoptosis and Structure resulting from tissue repair process:

  • SNOMED CT concept

    • Body structure (body structure)

      • Body structure, altered from its original anatomical structure (morphologic abnormality)

        • Apoptosis (morphologic abnormality)

        • Morphologically abnormal structure (morphologic abnormality)

        • Structure resulting from tissue repair process (morphologic abnormality)

The concepts in the morphologic abnormality hierarchy represent abnormal body structures.

Creating new morphologies

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

When considering the creation of a new morphological abnormality concept, consider the following:

  • When the name of a potentially new morphology is the same as the disease, creation of that new morphologic abnormality concept may not be beneficial since it would not be very morphologically descriptive.

  • Determine if there is benefit in creating a new morphology for a very small number of rarely used leaf nodes. If the new morphology is needed to differentiate two non-leaf concepts, that would be sufficient to create the new morphology. Otherwise, use the nearest existing morphologic abnormality.

  • Including a body site in a morphological abnormality concept is forbidden unless there is a clear modeling and pathological need.

Morphologic Abnormalities vs. Findings

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Concepts from the Morphologic Abnormality hierarchy should not be used in place of concepts from the Clinical Findings hierarchy, even though they appear to refer to similar clinical situations.

  • For example

    • 4147007 | Mass (morphologic abnormality)| is not a finding, but 300848003 | Mass of body structure (finding)| is a finding

Morphologies are used as the values of the defining attributes of findings and procedures. Findings are used to represent the combination of a morphology and a location.

  • For example

    • 300923002 | Cyst of scalp (disorder)| represents cystic type of morphology that has the location, scalp

Many morphologies have names that could be misinterpreted as implying a process rather than a structure.

Inflammation might mean the structural-morphologic features of inflammation, such as inflammatory cell infiltrates; or it might mean the process that causes the structural changes. Within the morphologic abnormality hierarchy, the structural interpretation is intended, not the process interpretation.

Combining morphologies

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

When modeling a concept requiring two role groups with the same finding site/body structure but two different morphologies (because a combined morphology does not exist), then those two morphologic abnormalities can be combined to create a new single, combined |(morphologic abnormality)| concept. Keep the newly created morphologic abnormality concept primitive as all morphologic abnormality concepts should be primitive. Limit the combination to two morphological concepts into a single concept; combining more than two morphological concepts into a single combined concept is not permitted.

Example, If 400067002 |Acantholytic epidermal nevus (disorder)| had the same Finding site of |Skin structure (body structure)| with two different morphologic abnormalities of |Epidermal nevus (morphologic abnormality)| and |Acantholysis (morphologic abnormality)|, then those two morphologic abnormality concepts can be combined to create a single, primitive, morphologic abnormality concept of |Acantholytic epidermal nevus (morphologic abnormality)|. This will prevent modeling with two relationship groups.

Instead of modeling as per this diagram in the stated view with two morphologies of the same finding site:

Model as in the stated view of this diagram with a combined morphology:

Fracture

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Fractures should be agnostic as to whether they are pathologic or not, unless specified in the FSN or could only be caused by trauma (e.g. open fractures). Although most fractures are traumatic, there are some pathological fractures. Based on its FSN and text definition, if the word pathological is present, use Pathologic fracture (morphologic abnormality).

Concept
Finding site
Associated morphology

Tumor morphology

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

SNOMED CT accepts tumor concepts, as long as they are included in the International Classification of Diseases for Oncology (ICD-O). ICD-O has two coding systems for coding the site (topography) and the histology (morphology) of the neoplasm:

  • Topographical - Anatomical site of origin or the organ system

  • Morphological - Tumor cell type or histology and behavior, i.e. malignant versus benign

The topography code describes the site of origin of the neoplasms. The morphology

Multiple x morphologic abnormality

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Multiple x morphologies, such as 125291005 |Multiple cysts (morphologic abnormality)|, are currently subtypes of the “X” morphology. The “X” morphology concept represents a class rather than a singular instance, and this arrangement follows the open world assumption of the description logic in SNOMED CT.

  • For example,

    • Cyst of upper eyelid does not mean a single cyst on a single upper eyelid. It represents a class of cyst condition that at least appeared in an upper eyelid. This class would also include a cyst condition involving both upper and lower eyelids.

Provide Feedback
Provide Feedback
Provide Feedback
Provide Feedback

  • Leave Primitive

    The subhierarchy of 118956008 |Body structure, altered from its original anatomical structure (morphologic abnormality)| is to remain primitive. Authors are not to define morphologic abnormality concepts.

    Pages in this section:

    Abscess
    Combining morphologies
    Congenital anomaly
    Creating new morphologies
    Provide Feedback

    Morphologies can be combined to create a single morphologic abnormality concept where doing so creates a specialization of the morphology e.g. 55075001 |Bleeding ulcer (morphologic abnormality)|. Where morphologies are different e.g. abscess and cellulitis, they can not be combined.

    Combining morphologies to create a specialization is done when modeling a concept that requires two role groups with the same body structure and two morphology values. Creating a combined morphology concept enables one role group to be used.

    Subtypes of 108369006 |Neoplasm (morphologic abnormality)| are not to be combined. These morphologies represent histological cell types that are recognized internationally by pathologists, classified by WHO, and aligned with the ICD-O classification.

    Example: Modeling Traumatic vs. Pathological Fractures

    code describes the cell type of the tumor and its biologic activity, in other words, the characteristics of the tumor itself. The morphology code, combined with the appropriate topography, expresses the complete morphological assessment as stated by the pathologist.

    Although the behavior of a neoplastic morphological type is implicit knowledge in the pathology community, the behavior (benign, in situ, uncertain behavior, or malignant) must be included in the description in SNOMED CT to aid users, terminology authors, and mappers; and because over time, the behavior of a certain neoplastic cell type may change depending upon the latest scientific understanding, so clarity is important.

    SCT intends to avoid adding concepts that conflate the localization of a specific tumor type in a topographic location as opposed to a neoplastic cell type that is derived from a specialized cell in an organ, e.g. adenocarcinoma vs. renal clear cell carcinoma. One is general; the other is specific to a cell type.

    The naming pattern utilized for gene-derived neoplastic morphology terms will align with the WHO Classification of Tumours (IARC 'Blue Books'). Gene acronyms are not required to be expanded. This policy is an exception to SNOMED CT's requirement for expansion of acronyms.

    • For example,

      • 1186933006 |SMARCA4-deficient undifferentiated tumor (morphologic abnormality)|. The gene SMARCA4 is not required to be named with the expanded form of SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4.

  • A similar example is how |Retinitis of bilateral eyes (disorder)| is a subconcept of |Retinitis of left eye (disorder)| and |Retinitis of right eye (disorder)|.

  • Having the Multiple X morphologic abnormality concept as a subtype of the “X” morphology concept allows the disorder concepts defined by these “multiple X” morphologies to be sufficiently defined. One drawback of the current format is that classification results are not complete.

    • For example,

      • Multiple cysts of eyelid would not subsume cysts of upper and lower eyelids in the current concept model.

    Fracture
    Lump and mass
    Morphologic Abnormalities vs. Findings
    Multiple x morphologic abnormality
    Tumor morphology

    21351003 |Fracture of phalanx of foot (disorder)|

    Bone structure of phalanx of foot

    Fracture (morphologic abnormality)

    704168008 |Pathological fracture of phalanx of foot (disorder)|

    Bone structure of phalanx of foot

    Pathologic fracture (morphologic abnormality)

    Provide Feedback

    In the future, these disorder concepts may be updated with a more robust representation utilizing cardinality as part of the logical definition. However, this functionality is not available in the reasoner profile of SNOMED CT at this time.

    Provide Feedback

    This guidance is not being applied retrospectively so the concept 707496003 |Inflammation and consolidation (morphologic abnormality)| will be an exception to this rule as it already exists as a current concept.

    Older 'like' content may still use the two role groups. This content would also need to use the new combined morphology value to support correct subsumption.

    Neoplasm exception

    Provide Feedback

    For more information

    Visit ICD-O at

    Provide Feedback
    http://www.iacr.com.fr